Greenlight Capital Re (GLRE) Competitors $14.72 +0.07 (+0.48%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends GLRE vs. DGICA, GBLI, HRTG, UIHC, PTVCA, MHLD, RGA, RNR, ESGR, and HGShould you be buying Greenlight Capital Re stock or one of its competitors? The main competitors of Greenlight Capital Re include Donegal Group (DGICA), Global Indemnity Group (GBLI), Heritage Insurance (HRTG), United Insurance (UIHC), Protective Insurance (PTVCA), Maiden (MHLD), Reinsurance Group of America (RGA), RenaissanceRe (RNR), Enstar Group (ESGR), and Hamilton Insurance Group (HG). These companies are all part of the "finance" sector. Greenlight Capital Re vs. Donegal Group Global Indemnity Group Heritage Insurance United Insurance Protective Insurance Maiden Reinsurance Group of America RenaissanceRe Enstar Group Hamilton Insurance Group Donegal Group (NASDAQ:DGICA) and Greenlight Capital Re (NASDAQ:GLRE) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings, valuation and community ranking. Which has more risk & volatility, DGICA or GLRE? Donegal Group has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500. Comparatively, Greenlight Capital Re has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Does the MarketBeat Community favor DGICA or GLRE? Donegal Group received 34 more outperform votes than Greenlight Capital Re when rated by MarketBeat users. However, 60.33% of users gave Greenlight Capital Re an outperform vote while only 56.19% of users gave Donegal Group an outperform vote. CompanyUnderperformOutperformDonegal GroupOutperform Votes21856.19% Underperform Votes17043.81% Greenlight Capital ReOutperform Votes18460.33% Underperform Votes12139.67% Which has better valuation & earnings, DGICA or GLRE? Greenlight Capital Re has lower revenue, but higher earnings than Donegal Group. Greenlight Capital Re is trading at a lower price-to-earnings ratio than Donegal Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDonegal Group$927.34M0.58$4.43M$0.7620.92Greenlight Capital Re$667.08M0.77$86.83M$2.525.84 Do analysts prefer DGICA or GLRE? Donegal Group currently has a consensus price target of $15.00, suggesting a potential downside of 5.66%. Given Donegal Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe Donegal Group is more favorable than Greenlight Capital Re.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Donegal Group 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Greenlight Capital Re 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to DGICA or GLRE? In the previous week, Donegal Group had 5 more articles in the media than Greenlight Capital Re. MarketBeat recorded 8 mentions for Donegal Group and 3 mentions for Greenlight Capital Re. Greenlight Capital Re's average media sentiment score of 1.43 beat Donegal Group's score of 1.00 indicating that Greenlight Capital Re is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Donegal Group 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Greenlight Capital Re 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is DGICA or GLRE more profitable? Greenlight Capital Re has a net margin of 12.38% compared to Donegal Group's net margin of 2.54%. Greenlight Capital Re's return on equity of 13.95% beat Donegal Group's return on equity.Company Net Margins Return on Equity Return on Assets Donegal Group2.54% 3.95% 0.84% Greenlight Capital Re 12.38%13.95%4.68% Do insiders & institutionals believe in DGICA or GLRE? 28.0% of Donegal Group shares are owned by institutional investors. Comparatively, 41.5% of Greenlight Capital Re shares are owned by institutional investors. 5.0% of Donegal Group shares are owned by company insiders. Comparatively, 22.8% of Greenlight Capital Re shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryGreenlight Capital Re beats Donegal Group on 11 of the 17 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Greenlight Capital Re News Delivered to You Automatically Sign up to receive the latest news and ratings for GLRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GLRE vs. The Competition Export to ExcelMetricGreenlight Capital ReFire, marine, & casualty insurance IndustryFinance SectorNASDAQ ExchangeMarket Cap$512.70M$45.08B$10.45B$8.81BDividend YieldN/A7.49%10.15%4.07%P/E Ratio5.8410.3849.2917.82Price / Sales0.772.043,434.5974.55Price / Cash6.0219.6030.2932.53Price / Book0.872.382.914.68Net Income$86.83M$3.90B$994.27M$226.08M7 Day Performance1.66%3.19%-0.07%-1.04%1 Month Performance8.47%9.80%7.18%1.04%1 Year Performance30.50%58.79%24.37%26.28% Greenlight Capital Re Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GLREGreenlight Capital Re3.1404 of 5 stars$14.72+0.5%N/A+30.6%$510.30M$667.08M5.8430Short Interest ↓Positive NewsDGICADonegal Group3.4545 of 5 stars$15.90+0.1%$15.00-5.7%+12.2%$538.60M$927.34M20.92880GBLIGlobal Indemnity GroupN/A$34.00-0.7%N/A+2.1%$468.81M$528.13M9.21266HRTGHeritage Insurance4.1635 of 5 stars$12.17+0.4%$10.67-12.4%+64.9%$371.89M$735.50M4.87650Short Interest ↓Positive NewsUIHCUnited InsuranceN/AN/AN/AN/A$343.29M$455.42M-3.81269PTVCAProtective InsuranceN/A$23.27flatN/AN/A$329.41M$468.75M8.40490MHLDMaiden0.8265 of 5 stars$1.65-0.6%N/A-2.4%$164.87M$89.23M-2.5450RGAReinsurance Group of America4.8657 of 5 stars$226.98-0.1%$227.38+0.2%+43.3%$14.97B$18.57B20.843,900RNRRenaissanceRe4.506 of 5 stars$264.30-0.1%$293.00+10.9%+25.6%$13.74B$9.13B3.81925Analyst RevisionESGREnstar Group2.8691 of 5 stars$323.83+0.0%N/A+22.4%$4.93B$1.43B4.90830Analyst ForecastPositive NewsHGHamilton Insurance Group1.6511 of 5 stars$18.62+0.8%$21.43+15.1%+23.8%$1.87B$1.57B4.17550 Related Companies and Tools Related Companies Donegal Group Competitors Global Indemnity Group Competitors Heritage Insurance Competitors United Insurance Competitors Protective Insurance Competitors Maiden Competitors Reinsurance Group of America Competitors RenaissanceRe Competitors Enstar Group Competitors Hamilton Insurance Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GLRE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Greenlight Capital Re, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Greenlight Capital Re With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.